Related Experiment Videos
Hyperhomocyst(e)inemia as a risk factor after renal transplantation
D Ducloux1, G Motte, Z A Massy
1Department of Nephrology and Renal Transplantation, St Jacques Hospital, Besançon, France.
Annals of Transplantation
|May 31, 2002
Insights
Cardiovascular disease (CVD) is a major cause of death in kidney transplant patients. This review examines known CVD risk factors and discusses the impact of elevated homocysteine levels.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Cardiovascular disease (CVD) is a primary cause of mortality in renal transplant recipients.
- Identifying and managing CVD risk factors is critical in this patient population.
Purpose of the Study:
- To review established risk factors for cardiovascular disease in renal transplant recipients.
- To discuss the potential role of additional factors, such as elevated homocysteine levels, in CVD development.
Main Methods:
- Literature review of accepted cardiovascular disease risk factors.
- Discussion of emerging or less-understood risk factors in the context of renal transplantation.
Main Results:
- Established CVD risk factors remain significant in renal transplant recipients.
- Increased homocysteine levels are highlighted as a potential contributing factor to CVD in this group.
Conclusions:
- Managing traditional CVD risk factors is essential for improving outcomes in renal transplant patients.
- Further investigation into non-traditional risk factors like homocysteine may offer new therapeutic targets.
Abstract:
Cardiovascular disease (CVD) is one of the leading cause of mortality in renal transplant recipients. Authors review accepted CVD risk factors. The role of additional factors like increased homocysteine level is discussed.